Skip to main content

Medical Marijuana Extracts Ruling Could Open A Business Gateway In Arizona, Experts Say

The Arizona Supreme Court handed the state’s medical cannabis industry a significant legal win this week by ruling that extracts – including concentrates, edibles and other infused products – are legal.

So, do licensed medical marijuana businesses expect an immediate shift in day-to-day business operations now they can legally sell the products?

“We’ve been selling extracts from Day One, and we will continue to do so,” J.P. Holyoak, the owner of Phoenix-area dispensary chain Arizona Natural Selections, said after the “expected” ruling.

Holyoak and other industry stakeholders said the ruling means little more than business as usual for the many licensed dispensaries that continued selling extracts to MMJ customers while the case moved through the Arizona courts.

However, some industry watchers noted that this week’s ruling:

  • Puts an end to a saga that was watched by many in Arizona’s MMJ industry.
  • Gives official legal approval for edibles/infused sales, which were previously in question. And sales of such goods could prove an important element as the state’s cannabis market moves forward.

Gary Smith, one of the attorneys involved in the case, noted that the formal legal cover for companies that are already engaged in the production and sale of extracts and infused products – including the roughly 130 dispensaries operating in the state – may potentially open a gateway to a future market.

That’s especially true if the state legalizes recreational MJ next year, as some observers expect.

“I think it absolutely will open up greater opportunity for the different type of products and the variety,” Smith said.

The formal stamp of approval from the state comes in a fast-growing cannabis subsector: infused products.

According to state health department statistics, Arizona dispensaries sold just over 10,000 pounds of edibles and other infused products last year compared with more than 111,000 pounds of flower.

As of April this year, Arizona dispensaries sold over 4,558 pounds of edibles/infused products alongside more than 44,000 pounds of flower.

No raids, ‘not even once’

Smith explained that the ruling overturned what was seen by many as an outlying legal case in which a court of appeals ruled in June 2018 that extracts and infused products didn’t qualify as medical cannabis under state law.

Despite that ruling, there was no real crackdown by law enforcement on dispensaries that continued to sell infused products.

“You can look at the dispensaries and say that they’re devilishly reckless or incredible risk-takers, but a majority of dispensaries didn’t change their business model one iota when the appeals court ruled last year that extracts were (illegal),” Smith noted.

“Had the state really supported this notion that extracts and concentrates were illegal, you would have expected them to be raiding dispensaries. Yet it never happened – not even once.”

The bigger risk was for the customers of licensed dispensaries. The court’s ruling centered on one patient who spent two years in jail for possessing just 0.05 ounces of hash, which Smith noted could have been any number of patients.

Moving forward

Since extracts are a hugely popular product segment and one of the quickest-growing, the state Supreme Court’s ruling could potentially lead to a new expansion of brands in Arizona, particularly those from out of state that may be looking to carve out some market share.

“There are more brands that will look at Arizona as a possible expansion,” predicted Lilach Mazor Power, co-founder of the Giving Tree Dispensary in Phoenix.

But it’s not like there’s going to be a rush of new edible products or companies opening in Arizona after the ruling, in part because the only businesses allowed to make those products are vertically integrated dispensaries, many of which already have their own extract brands.

Therefore, the new business opportunity would be through brand licensing, which is most likely to present itself from out-of-state companies that want a way into the Arizona market.

“I don’t think we’re going to see a huge change, because Arizona is saturated,” Power added. “We have 200-plus brands. This is a pretty big market.”

Power said her shop alone carries 32 brands of extracts and edibles, with 206 different stock keeping units, or SKUs.

The ruling also could help lay some groundwork for an expected recreational legalization ballot measure in 2020, which is still being drafted but is all but ready to roll out publicly, according to several sources.

The last rec MJ ballot measure in Arizona failed by a thread in 2016, and several in the Arizona cannabis space have been working on a follow-up campaign this year.

Now that the legality of extracts is settled – and if Arizona approves recreational use next year – those products likely will play an important role in the industry’s future in the state, Smith said.

“That whole (adult-use) market, obviously untapped yet, is going to be tremendous. I think it’s going to make the current medical market quite small by comparison,” he said.

John Schroyer can be reached at [email protected]

Original Article Source: https://mjbizdaily.com/medical-marijuana-extracts-ruling-could-open-a-business-gateway-arizona/

Comments

Popular posts from this blog

Could CBD Lead To The Development Of Safer Antipsychotic Medications?

Antipsychotic medications are important for managing a number of different psychiatric ailments, including bipolar disorders, schizophrenia, and even dementia. These drugs can greatly improve the manageability of symptoms that often distort one’s experience of reality. They can also create major mood disruptions and lead to a number of behavioral and emotional difficulties. Antipsychotic and anti-psychosis medications can be life-changing for people with such disorders, enabling them to live more normal and manageable lives without their symptoms taking over. These drugs work by regulating neurotransmitters in the brain so that naturally occurring imbalances and dysfunctions no longer disrupt mental and emotional processes. Often, reaching this outcome is much easier said than done; it can take a lot of time to find courses and combinations of treatments that work. It’s sometimes necessary to make adjustments to find the right balance for the individual and it’s not unusual for outc...

A Dozen US Governors Ask Congressional Leaders To Back Federal Marijuana Reform

A bipartisan coalition of 12 governors from states that have legalized medical or recreational cannabis  sent a letter to congressional leaders, asking for their support in getting a major marijuana reform bill through the U.S. House and Senate. The governors of California, Colorado, Maryland, Massachusetts, Nevada, New York, North Dakota, Oregon, Pennsylvania, Utah, Vermont and Washington state are backing  the STATES Act  – which would codify in federal law that marijuana regulations are to be left to the states instead of the federal government – while also seeking protections on banking and tax issues for the MJ industry. “The STATES Act is not about whether marijuana should be legal or illegal; it is about respecting the authority of states to act, lead and respond to the evolving needs and attitudes of their citizens,” the governors wrote. The letter also expressed support for the SAFE Banking Act , which was approved in March by a House committee. Tha...

Cannabis Watch: Canopy Growth To Book Charge Of Up To $568 Million As Marijuana Restructuring Continues

Canopy Growth Corp. said early Thursday it was halting a range of operations across three continents and expects its restructuring plans to result in a charge of up to C$800 million (567.9 million) in the fiscal fourth quarter. U.S.-traded shares US:CGC CA:WEED of the cannabis company fell 1.9% in afternoon trading. Canopy said it was selling operations in Africa, curtailing cultivation of hemp in the U.S. and Columbia, and shutting down an indoor production facility in Canada. The announcement will result in 85 job cuts, the company said. “When I arrived at Canopy Growth in January, I committed to conducting a strategic review in order to lower our cost structure and reduce our cash burn,” Canopy Chief Executive David Klein said in a statement. Read: As cannabis industry stays largely quiet on coronavirus, this CEO has been sounding the alarm Canopy’s restructuring announcement was expected by investors, Cowen analyst Vivien Azer wrote in a note to clients Thursday. Azer rate...